Align Technology (ALGN) Investor Day 2025 summary

Strategic vision and market opportunity

• Focus on making digital tooth movement the standard of care, expanding from orthodontics to comprehensive dentistry globally.

• 75% of the global population has malocclusion, representing a vast untapped market for clear aligners and digital dental solutions.

• Emphasis on growing the teen and kids segment, with significant investments in products like Invisalign First and palate expanders.

• Expansion into general practitioner (GP) and DSO channels, with tailored products and digital workflows to drive adoption.

• Geographic diversification with strong growth in APAC, EMEA, and emerging markets, supported by local manufacturing and education initiatives.

Technology and product innovation

• Continued leadership in 3D printing, AI, and machine learning, enabling mass customization and rapid treatment planning.

• Direct fabrication (direct fab) 3D printing platform to reduce material waste, lower costs, and enable new device designs.

• iTero Lumina scanner redefines intraoral scanning with faster, more accurate, and integrated diagnostics and restorative workflows.

• Exocad integration empowers labs and GPs to incorporate tooth movement into restorative procedures, preserving enamel and improving outcomes.

• Digital tools like ClinCheck, Outcome Simulator Pro, and virtual care apps enhance patient engagement, compliance, and practice efficiency.

Financial guidance and operational efficiency

• 2025 guidance: revenue growth of 3.5%-5.5% and clear aligner volume growth of about 5%, assuming no macroeconomic improvement.

• 2026-2028 outlook: 5%-15% annual revenue and volume growth, driven by new products, market expansion, and operational improvements.

• ASPs expected to decline slightly due to product mix and emerging market growth, but gross margins to improve with scale and efficiency.

• Commitment to maintaining operating margins at or above 25% long-term, with gross margins targeted above 73% as scale increases.

• Capital allocation prioritizes business investment, innovation, and shareholder returns, including a new $1 billion share buyback.